Comcast RISE

If your Florida startup is a high-tech company, you might be eligible for a Florida High Tech Corridor grant. These grants are designed for research and development projects and partner businesses with researchers at the University of Central Florida and the University of South Florida. Opportunities are available in 23 Florida counties. Eligible businesses work with university researchers to create a project plan and budget, as well as to submit the application. Applications are accepted throughout the year. If approved, funds of up to $150,000 are distributed directly to the university research team.

The FY 2026 National Technical Assistance Programs (NTAP) cooperative agreement supports three national organizations to develop and deliver technical assistance (TA) to existing and potential health centers with a focus on: Supporting the delivery of comprehensive, high-quality primary health care; improving chronic disease management, nutrition, and preventive services; improving operational effectiveness, efficiency, and quality; addressing emergent public health needs and priorities; complying with and exceeding Health Center Program and supplemental funding requirements.

Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of experts in addiction related data science is critical. The purpose of this Notice is to facilitate the entry of investigators to the area of addiction-related data science, including newly independent data scientists or established investigators seeking to incorporate novel and cutting-edge data science methodologies into their research programs for the first time. Through this opportunity, investigators will propose to apply emerging data science methods to answer critical questions requiring advanced data analytic strategies. Projects should be small in scale and answer specific research questions or provide preliminary data for a larger scale project. Applicants are encouraged to use existing datasets, follow FAIR principles, and, when applicable, attend to ethical concerns in the conduct of research involving human subjects. Ultimately, the aim is to expedite the development of robust research programs focused on the convergence of innovative data science techniques and addiction research, with initial projects serving as precursors for subsequent, more expansive research projects.

Transportation emissions remain the largest source of greenhouse gas pollution in the New Jersey, contributing to climate change impacts like rising temperatures, rising sea levels, and more extreme weather events. They also serve as a significant contributor for other air pollutants, like NOx and particulate matter, which have harmful environmental and health effects. Moving toward transportation electrification addresses these concerns because electric vehicles (EVs) do not produce any tailpipe emissions. New Jersey’s low-income communities and communities of color have historically been subject to an unreasonably high number of environmental and public health stressors, including transportation emissions. As a result, residents in these areas suffer from increased adverse health effects including, but not limited to, asthma, cancer, elevated blood lead levels, cardiovascular disease, and developmental disorders. Electric mobility solutions like carshare, rideshare, and ride hailing services provide additional modes of transport for residents in underserved areas, who often don’t own a personal vehicle and rely on public transportation. eMobility will help ensure they have access to and can benefit from the advantages of clean vehicle technology.

The purpose of this Funding Opportunity (NOFO) is to solicit grant applications to support research on the discovery and development of interventions to prevent and/or treat substance use disorders (SUDs) and overdose, including medications and medical devices to treat co-morbid SUDs. This includes preclinical and clinical research studies that will have high impact and quickly yield the necessary results to advance candidate interventions closer to regulatory approval or clinical adoption.